PolyPeptide Group AG (PPGN) — Net Asset Momentum
PolyPeptide Group AG (PPGN) recorded a net asset momentum of -6.3% as of December 2024, with net assets of CHF357.24 Million CHF. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See what is PolyPeptide Group AG's book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
PolyPeptide Group AG Net Asset Momentum (2018–2024)
This chart tracks PolyPeptide Group AG's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is -6.3%, with net assets of CHF357.24 Million CHF as of December 2024. For live market cap and overall valuation, see PPGN market cap overview.
Annual Net Asset History for PolyPeptide Group AG (2018–2024)
The table below shows the complete annual net asset history for PolyPeptide Group AG from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check PolyPeptide Group AG (PPGN) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CHF) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CHF357.24 Million | CHF756.58 Million | CHF399.33 Million | ▼ -6.3% |
| 2023 | CHF381.23 Million | CHF689.09 Million | CHF307.86 Million | ▼ -9.6% |
| 2022 | CHF421.68 Million | CHF575.78 Million | CHF154.10 Million | ▲ +0.1% |
| 2021 | CHF421.17 Million | CHF595.04 Million | CHF173.87 Million | ▲ +137.1% |
| 2020 | CHF177.66 Million | CHF375.98 Million | CHF198.31 Million | ▲ +18.9% |
| 2019 | CHF149.42 Million | CHF305.14 Million | CHF155.73 Million | ▲ +1.2% |
| 2018 | CHF147.67 Million | CHF283.83 Million | CHF136.15 Million | — |